Results 31 to 40 of about 5,863 (174)

Bilateral Chylothorax After 13 Years of Dasatinib Therapy in a Patient With Chronic Myeloid Leukaemia: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
A 52‐year‐old man with chronic myeloid leukaemia developed bilateral chylothorax after 13 years of dasatinib therapy, presenting with progressive dyspnea. Although pleural effusion is a relatively common adverse effect of dasatinib, chylothorax is an extremely rare complication.
Riku Watanabe   +6 more
wiley   +1 more source

A Case Series of Lymphangioleiomyomatosis, a Rare Cystic Lung Disease

open access: yesRespirology Case Reports, Volume 14, Issue 3, March 2026.
We studied five women with a rare lung condition called LAM that typically affects only 1–5 women per 10 million. All patients had breathing difficulties and characteristic lung scans showing multiple thin‐walled air sacs. Finding five cases at one center in just 2 years suggests this condition might be more common than previously thought or often goes
Sümeyye Sedef, Pınar Mutlu
wiley   +1 more source

Adverse Renal Outcomes in Patients With Mesothelioma—A Territory‐Wide Real‐World Data

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Advances in mesothelioma management have translated into longer patient survival and different treatment‐related side effects including nephrotoxicity. The risk of developing adverse renal outcomes in patients with mesothelioma and associated risk factors remains undefined.
Wang Chun Kwok   +3 more
wiley   +1 more source

Talcoma: A Diagnostic Challenge in Differential Diagnosis of Pleural Masses

open access: yesCase Reports in Radiology, 2015
Talcoma is a pleural mass which may develop as a rare complication following talc pleurodesis. Talc pleurodesis is performed to obliterate the pleural space to prevent recurrent pleural effusions or persistent pneumothoraces.
Iclal Ocak, Rohit Dewan
doaj   +1 more source

Adult‐Onset Primary Pleura Ewing Sarcoma With Recurrent Pleural Effusion: A Case Report and Literature Review

open access: yesRespirology Case Reports, Volume 14, Issue 2, February 2026.
We present a case of a 42‐year‐old woman presenting with pleural effusion, a rare manifestation of Ewing sarcoma. ABSTRACT Extraskeletal Ewing sarcoma (EES) is a rare malignant tumour within the “Ewing family of tumours,” first described by Tefft et al. in 1969.
Hamza Khan Khattak   +6 more
wiley   +1 more source

Impact of systemic steroid treatment on talc pleurodesis: a report of six cases

open access: yesJournal of Pharmaceutical Health Care and Sciences, 2020
Background Instillation of sterile graded talc in the pleural space is performed to prevent reaccumulation of malignant pleural effusion after drainage.
Soichiro Ishii   +4 more
doaj   +1 more source

Sotatercept in Pulmonary Langerhans Cell Histiocytosis‐Associated Pulmonary Hypertension: A Case Series and Systematic Review

open access: yesPulmonary Circulation, Volume 16, Issue 1, January 2026.
ABSTRACT Pulmonary Langerhans cell histiocytosis (PLCH) frequently complicated by pulmonary hypertension (PH), which markedly worsens prognosis. We retrospectively reviewed three institutional PLCH‐PH cases treated with off‐label Sotatercept added to background triple therapy and performed a systematic review of published PLCH‐PH reports (PubMed/Embase
Giorgi Chilingarashvili   +7 more
wiley   +1 more source

Which is the More Effective Option for Pleurodesis to Prevent the Recurrence of Malignant Pleural Effusion? Large-Particle Talc or Mistletoe Extract (ABNOVA Viscum Injection)

open access: yesJournal of Chest Surgery, 2023
Background: Malignant pleural effusion affects many patients with advanced cancer. When chemotherapy or radiotherapy fails to relieve malignant pleural effusion and related symptoms, drainage and pleurodesis can help. Although surgical talc pleurodesis
Changsung Han   +3 more
doaj   +1 more source

Transthoracic sonographic scores in evaluating the success of different scelerosing modalities in patients with malignant pleural effusion

open access: yesThe Egyptian Journal of Bronchology, 2022
Background Malignant pleural effusions (MPE) mostly arises from metastases to the pleura from other sites. Management of malignant effusions aims to palliate dyspnea and prevent the reaccumulation of pleural fluid to improve patients’ quality of life ...
Gamal Agmy   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy